BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12551823)

  • 1. Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies.
    Wieser R; Schreiner U; Rieder H; Pirc-Danoewinata H; Grüner H; Loncarevic IF; Fonatsch C
    Haematologica; 2003 Jan; 88(1):25-30. PubMed ID: 12551823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies.
    Bobadilla D; Enriquez EL; Alvarez G; Gaytan P; Smith D; Slovak ML
    Br J Haematol; 2007 Mar; 136(6):806-13. PubMed ID: 17341266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangements.
    Madrigal I; Carrió A; Gómez C; Rozman M; Esteve J; Nomdedeu B; Campo E; Costa D
    Cancer Genet Cytogenet; 2006 Oct; 170(2):115-20. PubMed ID: 17011981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.
    Ogawa S; Kurokawa M; Tanaka T; Tanaka K; Hangaishi A; Mitani K; Kamada N; Yazaki Y; Hirai H
    Leukemia; 1996 May; 10(5):788-94. PubMed ID: 8656673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome.
    Ogawa S; Kurokawa M; Tanaka T; Mitani K; Inazawa J; Hangaishi A; Tanaka K; Matsuo Y; Minowada J; Tsubota T; Yazaki Y; Hirai H
    Oncogene; 1996 Jul; 13(1):183-91. PubMed ID: 8700545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interphase fluorescence in situ hybridization assay for the detection of 3q21 rearrangements in myeloid malignancies.
    Wieser R; Schreiner U; Pirc-Danoewinata H; Aytekin M; Schmidt HH; Rieder H; Fonatsch C
    Genes Chromosomes Cancer; 2001 Dec; 32(4):373-80. PubMed ID: 11746978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.
    Baldazzi C; Luatti S; Zuffa E; Papayannidis C; Ottaviani E; Marzocchi G; Ameli G; Bardi MA; Bonaldi L; Paolini R; Gurrieri C; Rigolin GM; Cuneo A; Martinelli G; Cavo M; Testoni N
    Genes Chromosomes Cancer; 2016 Apr; 55(4):375-88. PubMed ID: 26815134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interphase cytogenetics of hematological cancer: comparison of classical karyotyping and in situ hybridization using a panel of eleven chromosome specific DNA probes.
    Poddighe PJ; Moesker O; Smeets D; Awwad BH; Ramaekers FC; Hopman AH
    Cancer Res; 1991 Apr; 51(7):1959-67. PubMed ID: 2004382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1.
    Storlazzi CT; Anelli L; Albano F; Zagaria A; Ventura M; Rocchi M; Panagopoulos I; Pannunzio A; Ottaviani E; Liso V; Specchia G
    Ann Hematol; 2004 Feb; 83(2):78-83. PubMed ID: 14551738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia.
    Vinatzer U; Mannhalter C; Mitterbauer M; Gruener H; Greinix H; Schmidt HH; Fonatsch C; Wieser R
    Genes Chromosomes Cancer; 2003 Jan; 36(1):80-9. PubMed ID: 12461752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements.
    Poppe B; Dastugue N; Vandesompele J; Cauwelier B; De Smet B; Yigit N; De Paepe A; Cervera J; Recher C; De Mas V; Hagemeijer A; Speleman F
    Genes Chromosomes Cancer; 2006 Apr; 45(4):349-56. PubMed ID: 16342172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.
    Goyama S; Kurokawa M
    Cancer Sci; 2009 Jun; 100(6):990-5. PubMed ID: 19385966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
    Wang HP; Li GX; Qiao ZH; Wang HW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple FISH assay for the detection of 3q26 rearrangements in myeloid malignancy.
    De Melo V; Vetter M; Mazzullo H; Howard JD; Betts DR; Nacheva EP; Apperley JF; Reid AG
    Leukemia; 2008 Feb; 22(2):434-7. PubMed ID: 17851560
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
    Sinclair P; Harrison CJ; Jarosová M; Foroni L
    Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
    Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional cytogenetics and breakpoint distribution by fluorescent in situ hybridization in patients with malignant hemopathies associated with inv(3)(q21;q26) and t(3;3)(q21;q26).
    De Braekeleer E; Douet-Guilbert N; Basinko A; Bovo C; Guéganic N; Le Bris MJ; Morel F; De Braekeleer M
    Anticancer Res; 2011 Oct; 31(10):3441-8. PubMed ID: 21965759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex variant Philadelphia translocations involving the short arm of chromosome 6 in chronic myeloid leukemia.
    La Starza R; Testoni N; Lafage-Pochitaloff M; Ruggeri D; Ottaviani E; Perla G; Martelli MF; Marynen P; Mecucci C
    Haematologica; 2002 Feb; 87(2):143-7. PubMed ID: 11836164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.